Education
About Us
Working with TipRanks
Follow Us
Avanos Medical, Inc. (DE:8HH)
:8HH
Total Valuation
Avanos Medical has a market cap or net worth of €500.28M. The enterprise value is €794.82M.
Market Cap€500.28M
Enterprise Value€794.82M
Share Statistics
Avanos Medical has 46,003,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,003,150
Owned by Insiders2.31%
Owned by Institutions0.05%
Financial Efficiency
Avanos Medical’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -37.63%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-37.63%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee308.85K
Profits Per Employee-176.07K
Employee Count2,227
Asset Turnover0.60
Inventory Turnover2.21
Valuation Ratios
The current PE Ratio of Avanos Medical is -1.87. Avanos Medical’s PEG ratio is >-0.01.
PE Ratio-1.87
PS Ratio0.00
PB Ratio0.88
Price to Fair Value0.88
Price to FCF8.83
Price to Operating Cash Flow7.27
PEG Ratio>-0.01
Income Statement
In the last 12 months, Avanos Medical had revenue of 687.80M and earned -392.10M in profits. Earnings per share was -8.52.
Revenue687.80M
Gross Profit381.30M
Operating Income-396.20M
Pretax Income-403.30M
Net Income-392.10M
EBITDA-345.60M
Earnings Per Share (EPS)-8.52
Cash Flow
In the last 12 months, operating cash flow was 100.70M and capital expenditures -17.80M, giving a free cash flow of 82.90M billion.
Operating Cash Flow100.70M
Free Cash Flow82.90M
Free Cash Flow per Share1.80
Dividends & Yields
Avanos Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change-39.01%
50-Day Moving Average12.88
200-Day Moving Average17.34
Relative Strength Index (RSI)41.10
Average Volume (3m)0.00
Important Dates
Avanos Medical upcoming earnings date is Apr 30, 2025, TBA Not Confirmed.
Last Earnings DateFeb 26, 2025
Next Earnings DateApr 30, 2025
Ex-Dividend Date―
Financial Position
Avanos Medical as a current ratio of 2.37, with Debt / Equity ratio of 20.54%
Current Ratio2.37
Quick Ratio1.53
Debt to Market Cap0.23
Net Debt to EBITDA-0.18
Interest Coverage Ratio-32.48
Taxes
In the past 12 months, Avanos Medical has paid -17.00M in taxes.
Income Tax-17.00M
Effective Tax Rate0.04
Enterprise Valuation
Avanos Medical EV to EBITDA ratio is -2.30, with an EV/FCF ratio of 9.59.
EV to Sales1.16
EV to EBITDA-2.30
EV to Free Cash Flow9.59
EV to Operating Cash Flow7.89
Balance Sheet
Avanos Medical has €107.70M in cash and marketable securities with $11.90M in debt, giving a net cash position of €62.50M billion.
Cash & Marketable Securities€107.70M
Total Debt$11.90M
Net Cash€62.50M
Net Cash Per Share€1.36
Tangible Book Value Per Share€5.67
Margins
Gross margin is 55.44%, with operating margin of -57.60%, and net profit margin of -57.01%.
Gross Margin55.44%
Operating Margin-57.60%
Pretax Margin-58.64%
Net Profit Margin-57.01%
EBITDA Margin-50.25%
EBIT Margin-56.86%
Analyst Forecast
The average price target for Avanos Medical is €15.04, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€15.04
Price Target Upside35.52% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―